financetom
Business
financetom
/
Business
/
CAMP4 Therapeutics seeks up to $80 mln proceeds in US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CAMP4 Therapeutics seeks up to $80 mln proceeds in US IPO
Oct 7, 2024 3:21 AM

Oct 7 (Reuters) - CAMP4 Therapeutics, a

biopharmaceutical company backed by healthcare giant Kaiser

Permanente, said on Monday it is targeting proceeds of up to $80

million for its initial public offering in the United States.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved